Stewart Krentzman, who had been Oki Data's executive vice president and COO since 2001, takes over as CEO, as the company continues its heated competition in the printer market against rivals ...
Katherine Haan is a small business owner with nearly two decades of experience helping other business owners increase their incomes. Katherine Haan is a small business owner with nearly two ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Poster presentation details: Poster Title: Preliminary results from PIKture-01, a First-in-Human Study of OKI-219, a mutant selective inhibitor of PI3Kα H1047R, in mutant selected solid tumors ...
From the end of November Market data will no longer be displayed here. As of 1:04 10 Nov 2024 15 min delay Source: Morningstar © 2024 BBC. The BBC is not responsible ...
OKI-219 is being investigated in the PIKture-01 clinical trial. PIKture-01 is a first-in-human study of the PI3KαH1047R Mutant-Selective Inhibitor OKI-219 as monotherapy in participants with ...
OKI-219 is being investigated in the PIKture-01 clinical trial. PIKture-01 is a first-in-human study of the PI3KaH1047R Mutant-Selective Inhibitor OKI-219 as monotherapy in participants with advanced ...
OnKure is currently developing OKI-219, a selective PI3Kα H1047R inhibitor, as its lead program. OnKure aims to become a leader in targeting oncogenic PI3Kα and has multiple programs designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback